Analysis of the VHL-HIF hydroxylase pathway
Analysis of the VHL-HIF hydroxylase pathway
批准号:
8100114
负责人:
YUZURU SHIIO
金额:
$21.53万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-25 至 2014-07-31
关键词:
Affinity ChromatographyApoptosisBacteriophagesBindingBinding ProteinsBiochemicalBiogenesisBiologicalBiological PhenomenaBiological ProcessBiologyCellsComplexEP300 geneHydroxylationHypoxia Inducible FactorInheritedIronIron ChelationIsotopically-Coded Affinity TaggingMediatingMediator of activation proteinMethodsMixed Function OxygenasesMolecular ProfilingMutationOncogene ProteinsOncogenesOxidative PhosphorylationOxygenPathway interactionsPheochromocytomaPlayPost-Translational Protein ProcessingProlineProteinsProteomicsRenal Cell CarcinomaRoleScreening procedureTechnologyTranscription CoactivatorTumor AngiogenesisTumor SuppressionTumor Suppressor GenesUbiquitinUbiquitinationVHL mutationanticancer researchbaseexpression cloningfollow-uphemangioblastomainterestmulticatalytic endopeptidase complexnovelnovel strategiesprotein complexprotein expressiontumortumorigenesisubiquitin ligase
中文摘要
描述(由申请人提供):泛素修饰蛋白在包括肿瘤发生在内的多种生物学现象中起关键调节作用。几种癌蛋白和抗癌蛋白显示泛素连接酶活性,鉴定它们的底物是癌症研究的中心主题之一。本申请旨在了解肿瘤抑制泛素连接酶VHL的生物学作用。VHL目前被最好地理解为缺氧诱导因子(HIF)的负调节因子。在氧和铁的存在下,HIF中特定的脯氨酸残基被羟基化,这些羟基化的脯氨酸被VHL识别,这导致HIF的泛素化和降解。VHL突变与遗传性和散发性肾细胞癌、血管母细胞瘤和嗜铬细胞瘤有关。一些证据表明,除了HIF之外,VHL还存在未鉴定的底物,其在肿瘤抑制中起关键作用。理解VHL功能(以及其他泛素连接酶的功能)的一个主要障碍是难以确定其泛素化底物。采用一种新的定量蛋白质组学技术,ICAT(同位素编码的亲和标签),我们开发了一种方法来系统地确定泛素连接酶的底物,并使用这种方法,我们确定了一种新的底物VHL,它带有VHL功能的关键介质的特性。因此,本申请的目的是分析该底物的泛素化的机制和生物学后果,并进行进一步的蛋白质组学筛选以鉴定VHL的其他底物。这些研究应该提供一个更好的了解VHL的生物学功能,并推进基于蛋白质组学的生物学的新生领域。
英文摘要
DESCRIPTION (provided by applicant): Protein modification with ubiquitin plays key regulatory roles in a wide variety of biological phenomena including tumorigenesis. Several oncoproteins and anti-oncoproteins display ubiquitin ligase activity and identification of their substrates is one of the central themes in cancer research. This application is directed toward understanding the biological roles of a tumor-suppressing ubiquitin ligase, VHL. VHL is currently best understood as a negative regulator of hypoxia inducible factor (HIF). In the presence of oxygen and iron, specific proline residues in HIF are hydroxylated and these hydroxylated prolines are recognized by VHL, which results in ubiquitination and degradation of HIF. VHL mutation is associated with hereditary and sporadic renal cell carcinomas, hemangioblastomas, and pheochromocytomas. Several lines of evidence suggest that, in addition to HIF, there are unidentified substrates for VHL which play critical roles in tumor suppression. A major barrier to understanding the VHL functions (as well as the functions of other ubiquitin ligases) has been the difficulty in pinpointing its ubiquitination substrates. Employing a novel quantitative proteomics technology, ICAT (isotope-coded affinity tag), we developed an approach to systematically identify the substrates of ubiquitin ligases and using this method, we identified a novel substrate for VHL, which carries the character of a key mediator of VHL functions. Therefore the aims of this application are to analyze the mechanism and biological consequence of ubiquitination of this substrate and to conduct further proteomic screens to identify additional substrates for VHL. These studies should provide a better understanding of the biological functions of VHL and advance the nascent field of proteomics-based biology.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Spider mites escape bacterial infection by avoiding contaminated food.
蜘蛛螨通过避免受污染的食物来逃避细菌感染。
DOI:
10.1007/s00442-018-4316-y
发表时间:
2019
期刊:
Oecologia
影响因子:
2.7
作者:
[Zélé,Flore, Santos-Matos,Gonçalo, Figueiredo,AlexandreRT, Eira,Cátia, Pinto,Catarina, Laurentino,TelmaG, Sucena,Élio, Magalhães,Sara]
通讯作者:
Magalhães,Sara
The role of the receptor complex and the cofactors in IGSF10 signaling
-
批准号:10728450
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2023
-
负责人:YUZURU SHIIO
-
依托单位:
A novel oncogenic driver in Ewing sarcoma
-
批准号:9321922
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2016
-
负责人:YUZURU SHIIO
-
依托单位:
A novel oncogenic driver in Ewing sarcoma
-
批准号:9179478
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2016
-
负责人:YUZURU SHIIO
-
依托单位:
Secretome Proteomics for VHL Tumor Biomarker Discovery
-
批准号:7740299
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2009
-
负责人:YUZURU SHIIO
-
依托单位:
Quantitative Proteomic Analysis of the Secretory Pattern of Senescent Cells
-
批准号:7187525
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
Analysis of the VHL-HIF hydroxylase pathway
-
批准号:7314758
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
Analysis of the VHL-HIF hydroxylase pathway
-
批准号:7500280
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
Analysis of the VHL-HIF hydroxylase pathway
-
批准号:7669079
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
Quantitative Proteomic Analysis of the Secretory Pattern of Senescent Cells
-
批准号:7348336
-
项目类别:
-
资助金额:$14.67万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
Analysis of the VHL-HIF hydroxylase pathway
-
批准号:7896480
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2007
-
负责人:YUZURU SHIIO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: